Genetics and Lifestyle Choices Can Affect Early Prostate Cancer DeathsJuly 11, 2024Genitourinary CancerPatient & Survivor CarePreventive Care
Should Cancer Trial Eligibility Become More Inclusive?July 10, 2024Practice ManagementPatient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Weight Loss Drugs Cut Cancer Risk in Diabetes PatientsJuly 8, 2024Preventive CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
Urticaria Linked to Higher Cancer Risk, Study FindsJuly 3, 2024Patient & Survivor CareMelanomaNonmelanoma Skin CancerMixed TopicsPediatricsDLBCLBreast Cancer
Time Warp: Fax Machines Still Common in Oncology Practice. Why?July 3, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGene Therapy
Cancer Drug Shortages Continue in the US, Survey FindsJuly 3, 2024Practice ManagementDLBCLPatient & Survivor CareMixed TopicsBreast CancerCNS/Brain CancerFollicular Lymphoma
EMA Greenlights Four Drugs for Bladder and Other CancersJuly 2, 2024Genitourinary CancerPatient & Survivor CareLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Neurofilament Light Chain Detects Early Chemotherapy-Related NeurotoxicityJune 26, 2024Neuro-oncologyPatient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal Cancer
Experts Focus on Quality-of-Life Data in Prostate CancerJune 26, 2024Genitourinary CancerPatient & Survivor Care
Oncology Mergers Are on the Rise. How Can Independent Practices Survive?June 25, 2024Practice ManagementRenal Cell CarcinomaSarcoma & GISTBreast CancerCNS/Brain CancerDLBCLFollicular Lymphoma
Doctors Endorsing Products on X May Not Disclose Company TiesJune 19, 2024Practice ManagementBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGene Therapy
One Patient Changed This Oncologist’s View of Hope. Here’s How.June 19, 2024Patient & Survivor CareBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastrointestinal CancerGenitourinary Cancer
FDA Expands Repotrectinib Label to All NTRK Gene Fusion+ Solid TumorsJune 14, 2024Patient & Survivor CareLung CancerPractice ManagementCNS/Brain CancerBreast CancerGastrointestinal CancerGenitourinary Cancer
Could British Columbia Eliminate Cervical Cancer by 2031?June 12, 2024Gynecologic CancerGenitourinary CancerPreventive CareDiversity in Medicine
HPV Vaccine Offers Cancer Protection Beyond Cervical CancerJune 11, 2024Gynecologic CancerGenitourinary CancerPreventive CarePatient & Survivor CareHead & Neck/Thyroid Cancers
